NONE |
Middle Market Apollo Institutional Private Lending |
May 14, 2024 |
0 |
$0 |
3 |
May 14, 2024 |
10%+ Owner |
EDR |
Endeavor Group Holdings, Inc. |
Apr 2, 2024 |
0 |
$0 |
3 |
Apr 9, 2024 |
Other* |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Mar 2, 2023 |
1 |
$522K |
4 |
Mar 3, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Mar 1, 2023 |
1 |
$388K |
4 |
Mar 2, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 28, 2023 |
1 |
$6.5K |
4 |
Mar 1, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 27, 2023 |
1 |
$404K |
4 |
Feb 28, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 24, 2023 |
1 |
$834K |
4 |
Feb 27, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 23, 2023 |
1 |
$404K |
4 |
Feb 24, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 22, 2023 |
1 |
$399K |
4 |
Feb 23, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 21, 2023 |
1 |
$731K |
4 |
Feb 22, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 17, 2023 |
1 |
$489K |
4 |
Feb 21, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 16, 2023 |
1 |
$337K |
4 |
Feb 17, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 14, 2023 |
1 |
$50.1K |
4 |
Feb 15, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 13, 2023 |
1 |
$259K |
4 |
Feb 14, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 10, 2023 |
1 |
$87.8K |
4 |
Feb 13, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Feb 1, 2023 |
1 |
$4.78K |
4 |
Feb 2, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Jan 26, 2023 |
1 |
$63K |
4 |
Jan 27, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Jan 25, 2023 |
1 |
$193K |
4 |
Jan 26, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Dec 23, 2022 |
11 |
$7.73M |
4 |
Jan 13, 2023 |
10%+ Owner |
RXRX |
RECURSION PHARMACEUTICALS, INC. |
Oct 27, 2022 |
1 |
$25M |
4 |
Oct 31, 2022 |
10%+ Owner |